FOXP3 and type 1 diabetes mellitus: TIM1+ Tregs and TMI4+ Tregs were significantly decreased in PBMCs of patients with T1D. Inhibition of TIM1 could reduce FOXP3 expression and inhibit Tregs development, while TIM4 regulated the activation of naive T cells and proliferation of activated T cells.